N ε -(Carboxymethyl)lysine (CML) Promotes Disorders of Glucose and Lipid Metabolism in Human Hepatic LO2 Cells
ACS Food Science & Technology · 20.10.2023 · 3 (10) · 1635-1645
DOI: 10.1021/acsfoodscitech.3c00176 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Food Science & Technology, online erschienen am 09.09.2023. Verfasst von Yi Wu und 8 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Advanced glycation end products (AGEs) are widely found in processed foods; their free fractions could significantly affect cellular glucose and lipid metabolism, but this mechanism remains poorly understood. We selected N ε -(carboxymethyl)lysine (CML) as a representative free AGE to study the biochemical processes involved in glucose metabolism, lipid synthesis, and catabolism in human LO2 cells. A combination of biochemical, metabolic flux, and comparative experiments revealed that the mechanism of CML intervention in glucose metabolism mainly involves promoting the dephosphorylation of glucose 6-phosphate and inhibiting the conversion of cis -aconitate to isocitrate in the Krebs cycle. Regarding lipid metabolism, CML combined with high-glucose stimulation synergistically promoted de novo lipogenesis, and CML also promoted fatty acid β-oxidation. These results provide constructive insights into the mechanisms and targets of the imbalance in cellular glucose and lipid metabolism induced by dietary AGEs.
Förderung
- Guangzhou Municipal Science and Technology Bureau
Zitieren
APA
Wu, Y., Wu, Y., Zhang, Z., Cai, J., Zong, M., Li, L., Zhang, X., Wu, H., & Li, B. (2023). N ε -(Carboxymethyl)lysine (CML) Promotes Disorders of Glucose and Lipid Metabolism in Human Hepatic LO2 Cells. ACS Food Science & Technology, 3(10), 1635-1645. https://doi.org/10.1021/acsfoodscitech.3c00176
Vancouver
Wu Y, Wu Y, Zhang Z, Cai J, Zong M, Li L, et al. N ε -(Carboxymethyl)lysine (CML) Promotes Disorders of Glucose and Lipid Metabolism in Human Hepatic LO2 Cells. ACS Food Science & Technology. 2023;3(10):1635-1645. doi:10.1021/acsfoodscitech.3c00176
BibTeX
@article{Wu2023,
author = {Wu, Yi and Wu, Yongtai and Zhang, Zhenhui and Cai, Jiaxian and Zong, Minhua and Li, Lin and Zhang, Xia and Wu, Hong and Li, Bing},
title = {N ε -(Carboxymethyl)lysine (CML) Promotes Disorders of Glucose and Lipid Metabolism in Human Hepatic LO2 Cells},
journal = {ACS Food Science & Technology},
year = {2023},
volume = {3},
number = {10},
pages = {1635--1645},
doi = {10.1021/acsfoodscitech.3c00176}
}
EUVIMED